LRCX

Lam Research
D

LRCX

Arincen83/100B

Lam Research revenue 1986–2027

Lam Research's revenue in Q1 FY2027, the three months to 27 September 2026, was 8.22B USD, up 54.4% on the same quarter a year before. Lam Research's revenue over the last twelve months was 26.13B USD, up 33.4% on the twelve months before. In fiscal year 2026 it was 23.23B USD, up 26.0% on the year before.

Last updated 8 Nov 2026 · Next report 27 Jan 2027

Revenue

Growth

Fiscal yearPeriod endingRevenueGrowthGross profitNet income
TTM27 Sept 202626.13B+33.36%13.34B8.45B
FY202628 Jun 202623.23B+26.02%11.73B7.27B
FY202529 Jun 202518.44B+23.68%8.98B5.36B
FY202430 Jun 202414.91B-14.47%7.05B3.83B
FY202325 Jun 202317.43B+1.16%7.78B4.51B
FY202226 Jun 202217.23B+17.78%7.87B4.61B
FY202127 Jun 202114.63B+45.61%6.81B3.91B
FY202028 Jun 202010.04B+4.05%4.61B2.25B
FY201930 Jun 20199.65B-12.85%4.36B2.19B
FY201830 Jun 201811.08B+38.23%5.17B2.38B
FY201730 Jun 20178.01B+36.15%3.60B1.70B
FY201630 Jun 20165.89B+11.91%2.62B914.05M
FY201530 Jun 20155.26B+14.15%2.28B655.58M
FY201430 Jun 20144.61B+28.02%2.01B632.29M
FY201330 Jun 20133.60B+35.03%1.40B113.88M
FY201230 Jun 20122.67B-17.68%1.08B168.72M
FY201130 Jun 20113.24B+51.74%1.50B723.75M
FY201030 Jun 20102.13B+91.21%969.94M346.67M
FY200930 Jun 20091.12B-54.91%388.73M-302.15M
FY200830 Jun 20082.47B-3.57%1.17B439.35M
FY200730 Jun 20072.57B+56.29%1.31B685.82M
FY200630 Jun 20061.64B+9.30%827.01M335.76M
FY200530 Jun 20051.50B+60.53%763.46M299.34M
FY200430 Jun 2004935.95M+23.93%431.05M82.99M
FY200330 Jun 2003755.23M-19.92%303.83M-7.74M
FY200230 Jun 2002943.11M-37.94%266.09M-90.05M
FY200130 Jun 20011.52B+23.48%657.47M52.11M
FY200030 Jun 20001.23B+89.95%539.61M204.76M
FY199930 Jun 1999647.96M-38.44%233.36M-112.91M
FY199830 Jun 19981.05B+5.01%406.08M-144.60M
FY199730 Jun 19971.00B-23.47%312.95M-33.63M
FY199630 Jun 19961.31B+64.10%655.70M145.90M
FY199530 Jun 1995798.21M+64.61%379.39M89.21M
FY199430 Jun 1994484.90M+86.14%237.30M37.80M
FY199330 Jun 1993260.50M+57.31%133.30M18.90M
FY199230 Jun 1992165.60M+20.00%89.20M9.90M
FY199130 Jun 1991138.00M+0.51%67.10M6.10M
FY199030 Jun 1990137.30M+8.97%67.10M-8.80M
FY198930 Jun 1989126.00M+68.00%61.00M9.30M
FY198830 Jun 198875.00M+194.12%39.90M2.30M
FY198730 Jun 198725.50M-25.87%14.50M-2.70M
FY198630 Jun 198634.40M—18.60M1.70M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Lam Research revenue growth by segment

Q1 FY2027 against Q1 FY2026

System5.73B
+61.6%
Customer Support and Other2.49B
+40.0%

Lam Research revenue by segment over time

System Customer Support and Other
Fiscal yearSystemCustomer Support and Other
FY202614.89B +29.5%8.35B +20.2%
FY202511.49B +28.8%6.94B +16.1%
FY20248.92B -16.6%5.98B -11.1%
FY202310.70B -5.5%6.73B +14.0%
FY202211.32B +15.9%5.90B +21.5%
FY20219.76B +47.4%4.86B +42.2%
FY20206.63B 3.42B

See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Lam Research's revenue

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.